Noberastine

Drug Profile

Noberastine

Alternative Names: R 64947

Latest Information Update: 01 Jul 1998

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Cilag AG
  • Class Antiallergics; Antiasthmatics; Antihistamines; Imidazoles; Pyridines; Small molecules
  • Mechanism of Action Histamine H1 receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Allergic rhinitis; Asthma

Most Recent Events

  • 01 Jul 1998 No-Development-Reported for Allergic rhinitis in Belgium (PO)
  • 01 Jul 1998 No-Development-Reported for Allergic rhinitis in USA (PO)
  • 01 Jul 1998 No-Development-Reported for Asthma in Belgium (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top